FRANK E. THOMAS - 29 May 2024 Form 4 Insider Report for Larimar Therapeutics, Inc. (LRMR)

Role
Director
Signature
/s/ Jennifer Johansson, Attorney-in-fact
Issuer symbol
LRMR
Transactions as of
29 May 2024
Net transactions value
$0
Form type
4
Filing time
31 May 2024, 16:58:04 UTC
Previous filing
15 Feb 2024
Next filing
14 May 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LRMR Stock Option (Right to Buy) Award $0 +19,000 $0.000000 19,000 29 May 2024 Common Stock 19,000 $7.07 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest on the earlier of (a) May 29, 2025 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company.